Please login to the form below

Not currently logged in
Email:
Password:

non-steroidal therapy

This page shows the latest non-steroidal therapy news and features for those working in and with pharma, biotech and healthcare.

Roche out-licenses lebrikizumab rights to Dermira

Roche out-licenses lebrikizumab rights to Dermira

Other competition is also in the offing including GlaxoSmithKline's asthma therapy Nucala (mepolizumab) and non-steroidal anti-inflammatory tapinarof, which are both in mid-stage testing for atopic dermatitis, and

Latest news

  • FDA green light for Pfizer's eczema drug FDA green light for Pfizer's eczema drug

    Pfizer's blockbuster-in-waiting Eucrisa has been approved by the FDA for eczema, becoming the first non-steroidal therapy for the skin condition in more than 15 years.

  • Pfizer adds eczema drug with $5.2bn Anacor acquisition Pfizer adds eczema drug with $5.2bn Anacor acquisition

    Pfizer adds eczema drug with $5.2bn Anacor acquisition. Expands innovative products business with non-steroidal therapy Crisaborole. ... and if approved would be the first new non-steroidal therapy for the skin condition in more than 15 years.

  • Novartis wins childhood arthritis indication for Ilaris in EU Novartis wins childhood arthritis indication for Ilaris in EU

    Ilaris gains a new indication as a monthly subcutaneous injection in patients aged two years and older who have not responded to therapy with non-steroidal anti-inflammatory drugs (NSAIDs) and ... The approval] represents another significant milestone in

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics